The Use of a Mitochondrial Enhancement Treatment in Bipolar Disorder: A Randomized, Placebo-Controlled Trial of Acetyl-L-Carnitine [levacecarnine] and Alpha-Lipoic Acid [thioctic acid] for the Treatment of Bipolar Depression.

Trial Profile

The Use of a Mitochondrial Enhancement Treatment in Bipolar Disorder: A Randomized, Placebo-Controlled Trial of Acetyl-L-Carnitine [levacecarnine] and Alpha-Lipoic Acid [thioctic acid] for the Treatment of Bipolar Depression.

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jul 2012

At a glance

  • Drugs Levacecarnine (Primary) ; Thioctic acid (Primary)
  • Indications Bipolar depression
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Jul 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
    • 29 Sep 2008 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top